It is time to support access to the drug Orkambi for people living with the most common mutation of cystic fibrosis (CF) - two copies of F508del.

A decision as to whether Orkambi can legally be made available in Australia will be made in March and the PBAC will meet at this time to decide whether to cover the cost of Orkambi.

We need the whole community to speak up and make sure these decisions are guided by the unique knowledge and experience of people living with CF.

Cystic Fibrosis Australia (CFA) and the state and territory CF organisations are committed to ensuring people with CF have access to therapies and drugs that improve and transform lives.



Our voices need to be loud and clear so please support CFA's petition for access to Orkambi.

Thank you for your support!

The team at Cystic Fibrosis Australia

P: 1300 232 823

W: cysticfibrosis.org.au

A: Rose Cottage, 2 Richardson Place, North Ryde NSW